A detailed history of International Assets Investment Management, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, International Assets Investment Management, LLC holds 686 shares of SUPN stock, worth $23,275. This represents 0.0% of its overall portfolio holdings.

Number of Shares
686
Previous 22 3018.18%
Holding current value
$23,275
Previous $589,000 96.26%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$25.77 - $35.16 $17,111 - $23,346
664 Added 3018.18%
686 $22,000
Q2 2024

Jul 30, 2024

BUY
$25.99 - $33.85 $571 - $744
22 New
22 $589,000
Q4 2023

Jan 24, 2024

BUY
$22.72 - $29.68 $14,472 - $18,906
637 New
637 $22,000
Q3 2023

Oct 04, 2023

BUY
$27.57 - $32.91 $606 - $724
22 New
22 $0
Q1 2023

Apr 19, 2023

BUY
$34.93 - $42.03 $768 - $924
22 New
22 $0

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.82B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track International Assets Investment Management, LLC Portfolio

Follow International Assets Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.